Major hepatectomy decreased tumor growth in an experimental model of bilobar liver metastasis.


Journal

HPB : the official journal of the International Hepato Pancreato Biliary Association
ISSN: 1477-2574
Titre abrégé: HPB (Oxford)
Pays: England
ID NLM: 100900921

Informations de publication

Date de publication:
10 2020
Historique:
received: 29 08 2019
revised: 15 12 2019
accepted: 14 02 2020
pubmed: 12 3 2020
medline: 26 10 2021
entrez: 12 3 2020
Statut: ppublish

Résumé

Two-stage hepatectomy (TSH), is associated with a risk of drop-out due to tumoral progression following portal vein occlusion (PVO). We explored the impact of majorhepatectomy on tumor growth by objective radiological measures comparing to PVO and minor hepatectomy, using a model of bilobar colorectal liver metastasis (CLM). CLM were induced in 48 BDIX rats by injection of DHDK12-cells. 7 days after cells injection, animals were distributed into 4 groups of equal number (n = 12): portal vein ligation (PVL), sham laparotomy (sham), minor (30%Phx) and major (70%Phx) hepatectomy. MR imaging was used for in vivo analysis of tumor implantation, growth and volumes. At POD10, tumour volumes were homogeneously distributed among the 4 groups. Lower TV were significantly observed after 70%Phx comparing to PVL at POD17 (0.63 ± 0.14cm3 vs 0.9 ± 0.16cm3, p = 0.008) and to the 3 others groups at POD24: 1.78 ± 0.38cm3 vs 3.2 ± 0.62cm3 (PVL, p = 0.019), 2.41 ± 0.74cm3 (Sham, p = 0.024) and 2.32 ± 0.59cm3 (30%PHx, p = 0.019). We confirmed in a reproducible model that contrary to PVO, a major hepatectomy decreases the growth of CLM in the remnant liver. This result leads to questioning the usual TSH and justifies exploring alternative strategies. The "major hepatectomy first-approach" should be an option to be evaluated.

Sections du résumé

BACKGROUND/PURPOSE
Two-stage hepatectomy (TSH), is associated with a risk of drop-out due to tumoral progression following portal vein occlusion (PVO). We explored the impact of majorhepatectomy on tumor growth by objective radiological measures comparing to PVO and minor hepatectomy, using a model of bilobar colorectal liver metastasis (CLM).
METHODS
CLM were induced in 48 BDIX rats by injection of DHDK12-cells. 7 days after cells injection, animals were distributed into 4 groups of equal number (n = 12): portal vein ligation (PVL), sham laparotomy (sham), minor (30%Phx) and major (70%Phx) hepatectomy. MR imaging was used for in vivo analysis of tumor implantation, growth and volumes.
RESULTS
At POD10, tumour volumes were homogeneously distributed among the 4 groups. Lower TV were significantly observed after 70%Phx comparing to PVL at POD17 (0.63 ± 0.14cm3 vs 0.9 ± 0.16cm3, p = 0.008) and to the 3 others groups at POD24: 1.78 ± 0.38cm3 vs 3.2 ± 0.62cm3 (PVL, p = 0.019), 2.41 ± 0.74cm3 (Sham, p = 0.024) and 2.32 ± 0.59cm3 (30%PHx, p = 0.019).
CONCLUSION
We confirmed in a reproducible model that contrary to PVO, a major hepatectomy decreases the growth of CLM in the remnant liver. This result leads to questioning the usual TSH and justifies exploring alternative strategies. The "major hepatectomy first-approach" should be an option to be evaluated.

Identifiants

pubmed: 32156510
pii: S1365-182X(20)30058-7
doi: 10.1016/j.hpb.2020.02.008
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1480-1489

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Auteurs

Lilian Schwarz (L)

Rouen University Hospital, Department of Digestive Surgery, 1 Rue de Germont, F-76031, Rouen Cedex, France; Normandie Univ, UNIROUEN, UMR 1245 INSERM, Rouen University Hospital, Department of Genomic and Personalized Medicine in Cancer and Neurological Disorders, F-76000, Rouen, France. Electronic address: lilian.schwarz@chu-rouen.fr.

Lionel Nicol (L)

Normandie Univ, UNIROUEN, Inserm U1096, FHU- REMOD-VHF, 76000 Rouen, France.

Arnaud Francois (A)

Rouen University Hospital, Department of Pathology, 1 Rue de Germont, F-76031, Rouen Cedex, France.

Paul Mulder (P)

Normandie Univ, UNIROUEN, Inserm U1096, FHU- REMOD-VHF, 76000 Rouen, France.

François Faitot (F)

Strasbourg University Hospital, Hôpital Hautepierre, Department of hepatobiliary and liver transplantation surgery, France.

Marie Dazza (M)

Rouen University Hospital, Department of Digestive Surgery, 1 Rue de Germont, F-76031, Rouen Cedex, France.

Petru Bucur (P)

Tours University Hospital, Department of Digestive Surgery and Liver Transplantation, France.

Céline Savoye-Collet (C)

Rouen University Hospital, Department of Radiology, 1 Rue de Germont, F-76031, Rouen Cedex, France; Normandie Univ, UNIROUEN, Quantif-LITIS EA 4108, Rouen University Hospital, France.

René Adam (R)

Department of Hepatobiliary and Liver Transplantation - Paul Brousse University Hospital, France.

Eric Vibert (E)

Department of Hepatobiliary and Liver Transplantation - Paul Brousse University Hospital, France.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH